DCF — THE AROOSTOOK MEDICAL CENTER
Enterprise Value: $-119.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-119.2M
Enterprise Value
$-39.9M
PV of Cash Flows
$-79.3M
PV of Terminal Value
$-127.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $138.8M | $-6.2M | -5.0% | $-12.1M | $-11.0M |
| Year 2 | $143.0M | $-5.0M | -4.0% | $-11.1M | $-9.1M |
| Year 3 | $147.3M | $-3.7M | -3.0% | $-9.9M | $-7.5M |
| Year 4 | $151.7M | $-3.0M | -2.0% | $-9.5M | $-6.5M |
| Year 5 | $156.3M | $-2.7M | -2.0% | $-9.3M | $-5.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-119.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$134.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000148367032
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5